The prevalence of advanced neoplasia in young adults with bleeding or weight loss who underwent a diagnostic colonoscopy exceeded 3%, a Cleveland Clinic study finds. The results reinforce that clinicians should not assume young age equals no colorectal cancer risk.
A new study presented at ASCRS 2018 is the first to show that radiated CAFs can promote tumor progression in colorectal cancer and how this occurs. Dr. David Liska explains.
CAFs present in the rectal tumor microenvironment, when treated with radiation, increase the secretion of factors that contribute to tumor growth and cell migration. What this finding means for future treatment.